NFKB1 and neoplasm: Labelle et al.7demonstrated that, after release of TGF-β and direct contact with tumor cells, platelets can activate tumor TGFβ/Smad and NF-κB pathways, enhancing tumor transition toward a more invasive phenotype and metastasis.